Cherry Creek Investment Advisors, Inc. Repligen Corp Transaction History
Cherry Creek Investment Advisors, Inc.
- $178 Million
- Q1 2024
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 3,647 shares of RGEN stock, worth $627,065. This represents 0.38% of its overall portfolio holdings.
Number of Shares
3,647
Previous 4,130
11.69%
Holding current value
$627,065
Previous $742,000
9.7%
% of portfolio
0.38%
Previous 0.47%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
521Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$1.34 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$877 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$614 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$302 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$252 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $9.54B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....